Wed, June 16, 2021
Tue, June 15, 2021
Mon, June 14, 2021

Brian Cheng Initiated (ADCT) at Buy and Held Target at $46 on, Jun 15th, 2021

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. -buy-and-held-target-at-46-on-jun-15th-2021.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
  • 🞛 This publication is a summary or evaluation of another publication
  • 🞛 This publication contains potentially derogatory content such as foul language or violent themes
Brian Cheng of Cantor Fitzgerald, Initiated "ADC Therapeutics SA" (ADCT) at Buy and Held Target at $46 on, Jun 15th, 2021.

Brian has made no other calls on ADCT in the last 4 months.



There are 2 other peers that have a rating on ADCT. Out of the 2 peers that are also analyzing ADCT, 0 agree with Brian's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Brian


  • Robert Burns of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $55 on, Friday, May 14th, 2021
  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Decreased Target to $53 on, Monday, May 10th, 2021